Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Dec 20, 2018
- Source ID
- 10.1172/jci.insight.120360
Entities
People
- Candace H. Cote
- Daniel M. Schreeder
- Daniel Y. Wang
- David L Rimm
- Douglas B. Johnson
- Emily Castellanos
- Jeffrey A. Sosman
- Jennifer Bordeaux
- Ju Young Kim
- Justin M. Balko
- Leora Horn
- Melinda E. Sanders
- Mellissa J. Nixon
- Mónica Valeria Estrada
- P. Brent Ferrell Jr.
- Paula I. Ericsson-gonzalez
- Phillip T. Dean
- Randall S. Davis
- Roberto Salgado
- Sherene Loi
- Susan R. Opalenik
- Violeta Sanchez
- Yaomin Xu
- Yu Wang
Organizations
- National Institutes of Health
- Office of the Director
- United States Department of Defense